130 related articles for article (PubMed ID: 7813562)
1. DP-1904, a specific inhibitor of thromboxane A2 synthesizing enzyme, suppresses ICAM-1 expression by stimulated vascular endothelial cells.
Ishizuka T; Suzuki K; Kawakami M; Kawaguchi Y; Hidaka T; Matsuki Y; Nakamura H
Eur J Pharmacol; 1994 Sep; 262(1-2):113-23. PubMed ID: 7813562
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells.
Ishizuka T; Suzuki K; Kawakami M; Hidaka T; Matsuki Y; Nakamura H
Eur J Pharmacol; 1996 Oct; 312(3):367-77. PubMed ID: 8894620
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 synthase inhibitor, DP-1904, decreases TNF alpha secretion from monocytes and inhibits E-selectin and ICAM-1 expression on the endothelial cell surfaces.
Kameda H; Yoshida T; Ichikawa Y; Homma M
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():423-5. PubMed ID: 7537434
[No Abstract] [Full Text] [Related]
4. Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells.
Petri MH; Tellier C; Michiels C; Ellertsen I; Dogné JM; Bäck M
Biochem Biophys Res Commun; 2013 Nov; 441(2):393-8. PubMed ID: 24161392
[TBL] [Abstract][Full Text] [Related]
5. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis.
Cayatte AJ; Du Y; Oliver-Krasinski J; Lavielle G; Verbeuren TJ; Cohen RA
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1724-8. PubMed ID: 10894809
[TBL] [Abstract][Full Text] [Related]
6. Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells.
May MJ; Wheeler-Jones CP; Pearson JD
Br J Pharmacol; 1996 Aug; 118(7):1761-71. PubMed ID: 8842442
[TBL] [Abstract][Full Text] [Related]
7. [The influence of erythropoietin (Epo) on intercellular adhesion molecule-1 (ICAM-1, CD54) and platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) expression on human umbilical vein endothelial cells (HUVEC) induced by tumor necrosis factor-alpha (TNF-alpha)].
Szczepański M; Kamianowska M; Wnuczko K; Pietruczuk M; Wołczyński S
Wiad Lek; 2007; 60(1-2):22-7. PubMed ID: 17607964
[TBL] [Abstract][Full Text] [Related]
8. An inhibitor of thromboxane production attenuates tumor necrosis factor release by activated human alveolar macrophages.
Kuhn DC; Stauffer JL; Gaydos LJ; Lacey SL; Demers LM
Prostaglandins; 1993 Sep; 46(3):195-205. PubMed ID: 8234828
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
10. Production of thromboxane A2 and prostaglandin i2 affected by interaction of heat aggregated IgG, endothelial cells, and platelets in lupus nephritis.
Kaneko N; Masuyama J; Nara H; Hirata D; Iwamoto M; Okazaki H; Minota S; Yoshio T
J Rheumatol; 2002 Oct; 29(10):2106-13. PubMed ID: 12375319
[TBL] [Abstract][Full Text] [Related]
11. Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells.
Mitsuhashi M; Tanaka A; Fujisawa C; Kawamoto K; Itakura A; Takaku M; Hironaka T; Sawada S; Matsuda H
J Immunol; 2001 Jan; 166(1):617-23. PubMed ID: 11123345
[TBL] [Abstract][Full Text] [Related]
12. Contractile effect of endothelin in human placental veins: role of endothelium prostaglandins and thromboxane.
Le SQ; Wasserstrum N; Mombouli JV; Vanhoutte PM
Am J Obstet Gynecol; 1993 Oct; 169(4):919-24. PubMed ID: 8238149
[TBL] [Abstract][Full Text] [Related]
13. Recombinant tumour necrosis factor-alpha and platelet-activating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro.
Sterner-Kock A; Braun RK; Schrenzel MD; Hyde DM
Immunology; 1996 Mar; 87(3):454-60. PubMed ID: 8778033
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of endothelin gene in cultured human mesangial cells and its modulation by transforming growth factor-beta, thrombin, and a thromboxane A2 analogue.
Zoja C; Orisio S; Perico N; Benigni A; Morigi M; Benatti L; Rambaldi A; Remuzzi G
Lab Invest; 1991 Jan; 64(1):16-20. PubMed ID: 1703585
[TBL] [Abstract][Full Text] [Related]
15. IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis.
Zavoico GB; Ewenstein BM; Schafer AI; Pober JS
J Immunol; 1989 Jun; 142(11):3993-9. PubMed ID: 2497185
[TBL] [Abstract][Full Text] [Related]
16. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction.
Molimard M; Martin CA; Naline E; Hirsch A; Advenier C
Eur J Pharmacol; 1995 May; 278(1):49-54. PubMed ID: 7545124
[TBL] [Abstract][Full Text] [Related]
17. Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells.
Ishizuka T; Kawakami M; Hidaka T; Matsuki Y; Takamizawa M; Suzuki K; Kurita A; Nakamura H
Clin Exp Immunol; 1998 Jun; 112(3):464-70. PubMed ID: 9649216
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
[TBL] [Abstract][Full Text] [Related]
19. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
de Chaffoy de Courcelles D; De Clerck F
Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha.
Bussolino F; Camussi G; Baglioni C
J Biol Chem; 1988 Aug; 263(24):11856-61. PubMed ID: 3261295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
